1 min read
Iambic Therapeutics Posts 142.6% Q3 Collaboration Revenue Growth
Collaboration revenue reached $11.4 million, beating estimates by $3.11 million, while GAAP earnings per share missed by $7.75.
Iambic Therapeutics, Inc. posted a 142.6% year-over-year increase in third-quarter collaboration revenue to $11.4 million, while its GAAP earnings per share missed analyst estimates by $7.75 per share.
Collaboration revenue was $3.11 million above estimates. The company’s GAAP earnings per share were -$8.52 for the quarter.